Korsana Biosciences (KRSA) Net Margin (2019 - 2025)
Korsana Biosciences' Net Margin was -111.54% in Q3 2025, up 261.14 percentage points from -372.68% a year earlier and up 236.84 percentage points from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) Net Margin (2019 - 2025) Analysis & Trends
On a trailing twelve-month basis, Korsana Biosciences' Net Margin was -77.02% through Sep 30, 2025, up 2645.14 percentage points year-over-year; for FY2024, it came in at -152.85%.
- Net Margin shows a five-year change of +2576.42 percentage points (FY2019 to FY2024).
- In earlier years, Net Margin was -14841.08% in FY2022 (-13530.90 pp), -1310.17% in FY2021 (+2078.42 pp) and -3388.59% in FY2020 (-659.32 pp).
- Quarterly Net Margin has moved between -14457.14% (Q4 2020) and 29.35% (Q4 2024) over five years.
- The best year-over-year quarter for Net Margin over five years was Q4 2021 (a gain of 12435.57 percentage points); the worst was Q4 2020 (a drop of 12697.86 percentage points).
- Per Business Quant data, KRSA's Net Margin in the three quarters before Q3 2025 was -348.39% (Q2 2025), -1764.20% (Q1 2025) and 29.35% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Korsana Biosciences | 16.27 Mn | 1.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -111.54% |
| Jun 30, 2025 | -348.39% |
| Mar 31, 2025 | -1,764.20% |
| Dec 31, 2024 | 29.35% |
| Sep 30, 2024 | -372.68% |
| Jun 30, 2022 | -4,375.16% |
| Mar 31, 2022 | -1,825.32% |
| Dec 31, 2021 | -2,021.58% |
| Sep 30, 2021 | -3,244.25% |
| Jun 30, 2021 | -539.40% |
| Mar 31, 2021 | -11,216.13% |
| Dec 31, 2020 | -14,457.14% |
| Sep 30, 2020 | -4,703.00% |
| Jun 30, 2020 | -2,608.01% |
| Mar 31, 2020 | -1,994.87% |
| Dec 31, 2019 | -1,759.28% |
| Sep 30, 2019 | -1,954.01% |
| Jun 30, 2019 | -1,981.20% |
API Access
Korsana Biosciences Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();